Loading…
Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis
Analysis of urine samples for a lectin-like factor in patients with a diagnosis of cystic fibrosis (CF) revealed that the low molecular weight (MW) factor is present in urine only from such patients and not from heterozygous carriers of the CF gene or from normal controls. The urine fraction contain...
Saved in:
Published in: | The American journal of the medical sciences 1990-02, Vol.299 (2), p.103-106 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433 |
---|---|
cites | cdi_FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433 |
container_end_page | 106 |
container_issue | 2 |
container_start_page | 103 |
container_title | The American journal of the medical sciences |
container_volume | 299 |
creator | Lieberman, Jack Schwartzman, Morton N. |
description | Analysis of urine samples for a lectin-like factor in patients with a diagnosis of cystic fibrosis (CF) revealed that the low molecular weight (MW) factor is present in urine only from such patients and not from heterozygous carriers of the CF gene or from normal controls. The urine fraction containing the factor must be separated from whole urine by a gel filtration column (TSK-20) for the activity to appear. The assay requires addition of an aliquot of normal serum to provide the necessary IgM to which the CF-factor binds, resulting in the lectin-like activity that causes agglutination of mouse erythrocytes. All 22 CF patients tested, who were not receiving intravenous (IV) antibiotics had positive CF-lectin urinary activity, whereas five others receiving IV aminoglycosides were negative. Four patients with a clinical diagnosis of CF, but with normal sweat tests (35–54 mEq/L), all had positive urinary CF-lectin tests. A blind study in which urine samples were shipped from Miami, FL to Sepulveda, CA was completely successful in correctly identifying 11 samples from CF patients as compared with ten from non-CF patients. It was concluded that an assay for urinary CF-lectin factor is specific and reliable for confirming a diagnosis of CF when the sweat test is indeterminate, and when patients have not received recent IV aminoglycosides. |
doi_str_mv | 10.1097/00000441-199002000-00005 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79607516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002962915361577</els_id><sourcerecordid>79607516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433</originalsourceid><addsrcrecordid>eNqFkEFvGyEQhVGVyHWS_oRKHKretmVgWeDoOnFTyVIOts-InYWKyt51YV3J_z44dn0NFzTvvRmGjxAK7Bswo76z06lrqMAYxngpqpMiP5ApSKErXuQbMi0Sr0zDzUdyl_MfxoBrEBMy4YJBLcWUrGY5uyMdAnV0k2Lv0pHOF9XS4xh7unA4Dom6XNyVx6Hv6GN0v_shjxHp2ueRhuLPj2_1IrZpyDE_kNvgttl_utz3ZLN4Ws-fq-XLz1_z2bJCYfRYNZ0KxksvNQtGaSUCaA3eCWwV8hZVx-vOhUbXHABBB8ml1KKVLWDAWoh78vU8d5-Gv4eyjN3FjH67db0fDtkq0zAloSlBfQ5i2S8nH-w-xV35qgVmTzztf572yvNNkqX18-WNQ7vz3bXxArD4Xy6-y-i2IbkeY77G6oY1SkCJ_TjHfOHxL_pkM0bfo-9iKqhtN8T3d3kF5kCPYg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79607516</pqid></control><display><type>article</type><title>Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis</title><source>Elsevier ScienceDirect Journals</source><creator>Lieberman, Jack ; Schwartzman, Morton N.</creator><creatorcontrib>Lieberman, Jack ; Schwartzman, Morton N.</creatorcontrib><description>Analysis of urine samples for a lectin-like factor in patients with a diagnosis of cystic fibrosis (CF) revealed that the low molecular weight (MW) factor is present in urine only from such patients and not from heterozygous carriers of the CF gene or from normal controls. The urine fraction containing the factor must be separated from whole urine by a gel filtration column (TSK-20) for the activity to appear. The assay requires addition of an aliquot of normal serum to provide the necessary IgM to which the CF-factor binds, resulting in the lectin-like activity that causes agglutination of mouse erythrocytes. All 22 CF patients tested, who were not receiving intravenous (IV) antibiotics had positive CF-lectin urinary activity, whereas five others receiving IV aminoglycosides were negative. Four patients with a clinical diagnosis of CF, but with normal sweat tests (35–54 mEq/L), all had positive urinary CF-lectin tests. A blind study in which urine samples were shipped from Miami, FL to Sepulveda, CA was completely successful in correctly identifying 11 samples from CF patients as compared with ten from non-CF patients. It was concluded that an assay for urinary CF-lectin factor is specific and reliable for confirming a diagnosis of CF when the sweat test is indeterminate, and when patients have not received recent IV aminoglycosides.</description><identifier>ISSN: 0002-9629</identifier><identifier>EISSN: 1538-2990</identifier><identifier>DOI: 10.1097/00000441-199002000-00005</identifier><identifier>PMID: 2301453</identifier><identifier>CODEN: AJMSA9</identifier><language>eng</language><publisher>Hagerstown, MD: Elsevier Inc</publisher><subject>Adolescent ; Adult ; Aminoglycosides ; Biological and medical sciences ; Chlorides - analysis ; Chromatography, Gel ; Chromatography, Ion Exchange ; Cystic Fibrosis ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - urine ; Female ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Lectin ; Lectins - urine ; Male ; Medical sciences ; Molecular Weight ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Sweat - analysis ; Sweat Test ; Tobramycin - pharmacology ; Urine</subject><ispartof>The American journal of the medical sciences, 1990-02, Vol.299 (2), p.103-106</ispartof><rights>1990 Southern Society for Clinical Investigation</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433</citedby><cites>FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002962915361577$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45779</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4606731$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2301453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lieberman, Jack</creatorcontrib><creatorcontrib>Schwartzman, Morton N.</creatorcontrib><title>Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis</title><title>The American journal of the medical sciences</title><addtitle>Am J Med Sci</addtitle><description>Analysis of urine samples for a lectin-like factor in patients with a diagnosis of cystic fibrosis (CF) revealed that the low molecular weight (MW) factor is present in urine only from such patients and not from heterozygous carriers of the CF gene or from normal controls. The urine fraction containing the factor must be separated from whole urine by a gel filtration column (TSK-20) for the activity to appear. The assay requires addition of an aliquot of normal serum to provide the necessary IgM to which the CF-factor binds, resulting in the lectin-like activity that causes agglutination of mouse erythrocytes. All 22 CF patients tested, who were not receiving intravenous (IV) antibiotics had positive CF-lectin urinary activity, whereas five others receiving IV aminoglycosides were negative. Four patients with a clinical diagnosis of CF, but with normal sweat tests (35–54 mEq/L), all had positive urinary CF-lectin tests. A blind study in which urine samples were shipped from Miami, FL to Sepulveda, CA was completely successful in correctly identifying 11 samples from CF patients as compared with ten from non-CF patients. It was concluded that an assay for urinary CF-lectin factor is specific and reliable for confirming a diagnosis of CF when the sweat test is indeterminate, and when patients have not received recent IV aminoglycosides.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aminoglycosides</subject><subject>Biological and medical sciences</subject><subject>Chlorides - analysis</subject><subject>Chromatography, Gel</subject><subject>Chromatography, Ion Exchange</subject><subject>Cystic Fibrosis</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - urine</subject><subject>Female</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Lectin</subject><subject>Lectins - urine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Molecular Weight</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Sweat - analysis</subject><subject>Sweat Test</subject><subject>Tobramycin - pharmacology</subject><subject>Urine</subject><issn>0002-9629</issn><issn>1538-2990</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNqFkEFvGyEQhVGVyHWS_oRKHKretmVgWeDoOnFTyVIOts-InYWKyt51YV3J_z44dn0NFzTvvRmGjxAK7Bswo76z06lrqMAYxngpqpMiP5ApSKErXuQbMi0Sr0zDzUdyl_MfxoBrEBMy4YJBLcWUrGY5uyMdAnV0k2Lv0pHOF9XS4xh7unA4Dom6XNyVx6Hv6GN0v_shjxHp2ueRhuLPj2_1IrZpyDE_kNvgttl_utz3ZLN4Ws-fq-XLz1_z2bJCYfRYNZ0KxksvNQtGaSUCaA3eCWwV8hZVx-vOhUbXHABBB8ml1KKVLWDAWoh78vU8d5-Gv4eyjN3FjH67db0fDtkq0zAloSlBfQ5i2S8nH-w-xV35qgVmTzztf572yvNNkqX18-WNQ7vz3bXxArD4Xy6-y-i2IbkeY77G6oY1SkCJ_TjHfOHxL_pkM0bfo-9iKqhtN8T3d3kF5kCPYg</recordid><startdate>19900201</startdate><enddate>19900201</enddate><creator>Lieberman, Jack</creator><creator>Schwartzman, Morton N.</creator><general>Elsevier Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19900201</creationdate><title>Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis</title><author>Lieberman, Jack ; Schwartzman, Morton N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aminoglycosides</topic><topic>Biological and medical sciences</topic><topic>Chlorides - analysis</topic><topic>Chromatography, Gel</topic><topic>Chromatography, Ion Exchange</topic><topic>Cystic Fibrosis</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - urine</topic><topic>Female</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Lectin</topic><topic>Lectins - urine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Molecular Weight</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Sweat - analysis</topic><topic>Sweat Test</topic><topic>Tobramycin - pharmacology</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lieberman, Jack</creatorcontrib><creatorcontrib>Schwartzman, Morton N.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of the medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lieberman, Jack</au><au>Schwartzman, Morton N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis</atitle><jtitle>The American journal of the medical sciences</jtitle><addtitle>Am J Med Sci</addtitle><date>1990-02-01</date><risdate>1990</risdate><volume>299</volume><issue>2</issue><spage>103</spage><epage>106</epage><pages>103-106</pages><issn>0002-9629</issn><eissn>1538-2990</eissn><coden>AJMSA9</coden><abstract>Analysis of urine samples for a lectin-like factor in patients with a diagnosis of cystic fibrosis (CF) revealed that the low molecular weight (MW) factor is present in urine only from such patients and not from heterozygous carriers of the CF gene or from normal controls. The urine fraction containing the factor must be separated from whole urine by a gel filtration column (TSK-20) for the activity to appear. The assay requires addition of an aliquot of normal serum to provide the necessary IgM to which the CF-factor binds, resulting in the lectin-like activity that causes agglutination of mouse erythrocytes. All 22 CF patients tested, who were not receiving intravenous (IV) antibiotics had positive CF-lectin urinary activity, whereas five others receiving IV aminoglycosides were negative. Four patients with a clinical diagnosis of CF, but with normal sweat tests (35–54 mEq/L), all had positive urinary CF-lectin tests. A blind study in which urine samples were shipped from Miami, FL to Sepulveda, CA was completely successful in correctly identifying 11 samples from CF patients as compared with ten from non-CF patients. It was concluded that an assay for urinary CF-lectin factor is specific and reliable for confirming a diagnosis of CF when the sweat test is indeterminate, and when patients have not received recent IV aminoglycosides.</abstract><cop>Hagerstown, MD</cop><pub>Elsevier Inc</pub><pmid>2301453</pmid><doi>10.1097/00000441-199002000-00005</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9629 |
ispartof | The American journal of the medical sciences, 1990-02, Vol.299 (2), p.103-106 |
issn | 0002-9629 1538-2990 |
language | eng |
recordid | cdi_proquest_miscellaneous_79607516 |
source | Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Aminoglycosides Biological and medical sciences Chlorides - analysis Chromatography, Gel Chromatography, Ion Exchange Cystic Fibrosis Cystic Fibrosis - diagnosis Cystic Fibrosis - urine Female Humans Investigative techniques, diagnostic techniques (general aspects) Lectin Lectins - urine Male Medical sciences Molecular Weight Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Sweat - analysis Sweat Test Tobramycin - pharmacology Urine |
title | Assay of a Urinary CF-Lectin Factor as a Second Diagnostic Test for Cystic Fibrosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A08%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assay%20of%20a%20Urinary%20CF-Lectin%20Factor%20as%20a%20Second%20Diagnostic%20Test%20for%20Cystic%20Fibrosis&rft.jtitle=The%20American%20journal%20of%20the%20medical%20sciences&rft.au=Lieberman,%20Jack&rft.date=1990-02-01&rft.volume=299&rft.issue=2&rft.spage=103&rft.epage=106&rft.pages=103-106&rft.issn=0002-9629&rft.eissn=1538-2990&rft.coden=AJMSA9&rft_id=info:doi/10.1097/00000441-199002000-00005&rft_dat=%3Cproquest_cross%3E79607516%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c398t-6d7f9e5e580f97873f1881ea3cb7c2bc7d24daf684211c18f525583b5b1cfc433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79607516&rft_id=info:pmid/2301453&rfr_iscdi=true |